Positron emission tomography (PET) is now a widely used clinical and research imaging technique for the study and diagnosis of a range of neurological, oncological and cardiac conditions. [1] [2] [3] [4] [5] The expansion of PET imaging centres worldwide over the past decade has led to an accompanying increase in demand for both new and existing PET tracers. The development of PET tracers presents a number of key chemical and biological challenges due to the short half-lives of positron-emitting nuclides, the peculiarity of tracer level chemical reactions, the complexity of biological interactions, and the strict working environment required for safe handling of radioactive substances. The synthetic chemistry hurdles are particularly apparent considering that the half-lives of the two most common PET nuclides, carbon-11 and fluorine-18, are only 20.4 min and 109.7 minutes, respectively. For example, a clinical radiopharmaceutical carbon-11 tracer production involving radiosynthesis, purification and formulation, typically needs to be complete within a 30-45 min timeframe. The development of new tracers is further confounded by the limited number of available PET precursors and methods for labelling, meaning that there are only a certain number of reactions that can be used to introduce the radionuclide. 6 This limitation clearly restricts access to what can ultimately be radiolabelled and where on the target molecule the radionuclide can be introduced. Despite these challenges, an array of novel fluorine-18 and carbon-11 labelling methods have been reported in recent years to try overcome these challenges. [7] [8] [9] [10] [11] [12] The thiocyanate ion is a 'pseudohalide' and potent nucleophile that can react either via the nitrogen atom or sulfur atom. It has been widely use to prepare organic thiocyanates and a range of other sulfur containing compounds (Scheme 1). 21 The thiocyanate ion is attractive from a radiolabelling perspective because of its reactivity and potential to form a wide range of organosulfur derivatives. 3 OH, acetonitrile 1 mL) followed by heating to 90°C for 5 min. Method B: addition of ammonia solution (50 μL, 2 M NH 3 in CH 3 OH) to [ 11 C]CS 2 in acetonitrile (1 mL) followed by heating to 90°C for 5 min.
b Non-isolated radiochemical yield (RCY) determined by analytical radio HPLC of the crude product based on conversion from α-thiocyanatophenones. We discovered that excellent conversions could be achieved for the C-11 thiocyanation of all seven α-ketobromides we tested, within a 5 min reaction time (Chart 1). Lower conversions were observed for the reaction of the diphenyl substrate (Chart 1, entry 8), most likely due to the greater steric hindrance of this substrate inhibiting nucleophilic attack of the thiocyanate ion. [ Thiocyanate compounds are interesting intermediates because they can be converted into other organosulfur and heterocyclic structures. [25] [26] [27] Thiazole structures are prevalent in a number of important naturally occurring compounds, for example thiamine and penicillin, and in a wide range of bioactive small molecules such as benzothiazoles, while the related thiazolones have been investigated for anti-cancer activity. 28 Carbon-11 radiolabelling within the ring of such sulfur based heterocyclic structures is challenging, and to the best of our knowledge has not been achieved until now. Since thiazolones can be accessed in high yield from α-thiocyanatophenones via an acid mediated cyclisation reaction (Scheme 4), we sought to explore this pathway using our in situ generated α-[ 11 C]thiocyanatophenones. 29 To test this in the radiochemistry laboratory, a solution of 1-phenyl-2-[ In 3 I we also expect that this method could be easily adopted by other PET centres with carbon-11 facilities.
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